Chronic Hepatitis B Virus

Patients with chronic hepatitis B who received antiviral therapy experienced a significant reduction in risk for cirrhosis, according to study results.

Gilead Sciences and Vir Biotechnology will collaborate on a study to research novel combination therapies for patients with chronic hepatitis B virus, according to a Gilead press release.